Latest Interest Rates News

MFF Capital Investments’ May update shows a modest fall in net tangible assets per share and outlines a cautious yet optimistic portfolio stance amid geopolitical tensions and technological advances.

Papyrus Australia has secured a key milestone under its TBS Mining Contract by executing a board production deal with a Vietnam manufacturer, while raising $325,000 to support commercial scale-up and facility establishment.

Sandon Capital has completed a $9 million conditional placement of notes, pending approval of a key Restructure Proposal by noteholders in June. The raise aims to support potential redemptions, working capital, and new investments.

2 Cheap Cars Group held its ground in a challenging FY26, delivering a net profit after tax of $3.2 million amid rising carbon costs and softer vehicle sales, supported by a robust second-half recovery and record finance penetration.

Nexalis Therapeutics has locked in a $53 million non-dilutive funding facility with Point8 Capital, replacing its previous lender and supporting three clinical programs targeting breakthrough cancer pain, panic disorder, and treatment-resistant depression.

Peet Limited has upgraded its FY26 net profit guidance by up to 17%, driven by accelerated construction and robust market demand in Western Australia and Queensland.

Promisia Healthcare reported a robust 29% increase in operating revenue for FY26, alongside a new dividend policy tied to operating free cash flow, setting the stage for continued growth in FY27.

Australian Vintage Limited has locked in a $128 million refinancing deal extending to 2029 and reported a significant cash flow turnaround in FY26, driven by innovation and strategic acquisitions.

PaySauce has successfully launched its Global Payroll Platform in Australia, targeting nearly 700,000 micro-businesses, supported by a $5 million capital raise and steady growth in its New Zealand operations.

ASX Limited projects a significant 18-21% rise in expenses for FY27 driven by technology modernisation and regulatory response, while increasing capital expenditure guidance to up to $200 million.

Ryman Healthcare reported a substantial reduction in net loss for FY26 alongside its first positive free cash flow in over a decade, driven by operational improvements, refinancing, and land divestments.

Sandon Capital is seeking noteholder approval to amend its 4.8% unsecured notes, offering an 8.5% fixed interest extension and monthly payments, alongside a $10 million conditional note placement.